We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Alkemy Capital Investments Plc | LSE:ALK | London | Ordinary Share | GB00BMD6C023 | ORD GBP0.02 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 87.50 | 85.00 | 90.00 | 87.50 | 87.50 | 87.50 | 19,817 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Offices-holdng Companies,nec | 0 | -2.65M | -0.3239 | -2.70 | 7.14M |
TIDMALK TIDMB
2024 financial calendar for ALK (ALKB:DC / OMX: ALK B / AKBLF):
Hot Features
Premium
-- 11 January 2024: Silent period
-- 8 February 2024: Annual report 2023
-- 14 March 2024 at 4.00 p.m.: Annual General Meetingto be held at
ALK Bøge Allé 12970 Hørsholm, Denmark Written
requests to have specific business transacted at the AGM will be included
in theagenda if received by the company on31 January 2024 at the
latest(may be emailed to investor@alk.net)
-- 5 April 2024: Silent period
-- 3 May 2024: Three-month interim report (Q1) 2024
-- 26 July 2024: Silent period
-- 23 August 2024: Six-month interim report (Q2) 2024
-- 17 October 2024: Silent period
-- 14 November 2024: Nine-month interim report (Q3) 2024
ALK-Abelló A/S
For further information please contact:
Investor Relations: Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525
Media: Maiken Riise Andersen, tel. +45 5054 1434
About ALK
ALK is a global specialty pharmaceutical company focused on allergy and allergic asthma. It markets allergy immunotherapy treatments and other products and services for people with allergy and allergy doctors. Headquartered in Hørsholm, Denmark, ALK employs around 2,800 people worldwide and is listed on Nasdaq Copenhagen. Find more information at www.alk.net.
Attachment
-- InvestorNews_20Dec23_FinancialCalendar
https://ml-eu.globenewswire.com/Resource/Download/0975be56-0ef8-4846-a4a0-5f87b81db652
(END) Dow Jones Newswires
December 20, 2023 04:45 ET (09:45 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Alkemy Capital Investments Chart |
1 Month Alkemy Capital Investments Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
